VAERS reports by lot

Novartis Vaccines Meningococcal lot 3YB52: VAERS reports

27 VAERS reports list lot 3YB52 as a Novartis Vaccines Meningococcal vaccine, received between 2022-08-08 and 2024-05-21. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
27
Reports
0%
Marked serious
0
With a death outcome
17
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1429%
Injection-site / Local reaction1122%
Neurological1020%
Musculoskeletal612%
Cardiac / Cardiovascular24%
Gastrointestinal24%
Dermatological (non-injection-site)24%
Allergic / Anaphylactic12%
Respiratory12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan6
Virginia2
Iowa2
North Carolina2
Georgia2
Minnesota1
California1
Idaho1
New Jersey1
South Carolina1
Pennsylvania1
Colorado1

Reports by month received

2022-083
2022-091
2022-102
2022-111
2022-123
2023-012
2023-021
2023-032
2023-053
2023-061
2023-071
2023-081
2023-091
2023-112
2023-121
2024-011
2024-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.